サマリー

再構成薬用バイアルアダプターの世界市場2022-2026年
Technavioは再構成薬用バイアルアダプター市場を監視しており、2022年から2026年の間に4億6098万ドル、予測期間中に7.57%のCAGRで進行することが予測されています。当レポートでは、再構成薬用バイアルアダプター市場の全体分析、市場規模と予測、動向、成長促進要因、課題、さらに約25社のベンダーを網羅したベンダー分析を行っています。
現在の世界市場のシナリオ、最新のトレンドとドライバー、市場全体の環境に関する最新の分析を提供しています。市場は、慢性疾患の増加、老年層の拡大、バイアルアダプターを使用する利点に関する意識の高まりによって牽引されています。また、慢性疾患の増加により、市場の成長も促進されると予想されます。
再構成薬用バイアルアダプター市場の分析には、治療分野セグメントと地理的展望が含まれます。
Technavioの再構成薬用バイアルアダプター市場は、以下のようにセグメント化されています。
治療分野別
- 感染症
- 自己免疫疾患
- 代謝性疾患
- その他
地域別状況
- 北米
- 欧州
- アジア
- その他の地域 (ROW)
本調査では、バイアルアダプターの製造に使用される原材料の価格変動が、今後数年間の再構成薬用バイアルアダプター市場の成長を促す主要因の1つであると特定しています。また、凍結乾燥薬剤の需要の高まりと技術の採用の増加が、同市場における相当量の需要につながるとしています。
Technavioは、複数のソースからのデータを調査、合成、総括する方法で、主要パラメータの分析により、市場の詳細な姿を提示します。再構成薬用バイアルアダプター市場に関する当レポートの対象領域は以下の通りです。
- 再構成薬用バイアルアダプター市場のサイジング
- 再構成薬用バイアルアダプター市場予測
- 再構成薬用バイアルアダプター市場の産業分析
Technavioの強力なベンダー分析は、顧客が市場での地位を向上できるように設計されており、これに沿って本レポートでは、Agilent Technologies Inc、Amsino International Inc、B. Braun Melsungen AG、Becton Dickinson and Co、Cole-Parmer Instrument Co, Ltd.、Co.Ltd.など、再構成薬用アダプタ市場の主要ベンダー数社の詳細分析を掲載しています。LLC、Corvida Medical、Dedecke GmbH、Helapet ltd.、Medtec Medical Inc、Merck KGaA、Mettler Toledo International Inc、Miltenyi Biotec B.V. and Co.などのベンダーが含まれます。KG、Raygroup SASU、Shimadzu Corp.、Simplivia、Stevanato Group S.p.A、Thermo Fisher Scientific Inc、West Pharmaceutical Services Inc、Healthmark Industries Company Inc.の各社が含まれる。また、再構成薬用バイアルアダプターの市場分析レポートには、今後の動向や市場成長に影響を与える課題に関する情報も含まれています。これは、企業が今後訪れるすべての成長機会を戦略化し、活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報および二次情報の客観的な組み合わせを使用して実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/vial-adaptors-for-reconstitution-drug-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータを調査、合成、総括する方法で、市場の詳細なイメージを提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示します。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法および分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Therapeutic Area
o Exhibit 06: Executive Summary – Chart on Incremental Growth
o Exhibit 07: Executive Summary – Data Table on Incremental Growth
o Exhibit 08: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Bargaining power of buyers – Impact of key factors in 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Therapeutic Area
o 5.1 Market segments
o Exhibit 24: Chart on Therapeutic Area - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Therapeutic Area - Market share 2021-2026 (%)
o 5.2 Comparison by Therapeutic Area
o Exhibit 26: Chart on Comparison by Therapeutic Area
o Exhibit 27: Data Table on Comparison by Therapeutic Area
o 5.3 Infectious diseases - Market size and forecast 2021-2026
o Exhibit 28: Chart on Infectious diseases - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Infectious diseases - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Infectious diseases - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Infectious diseases - Year-over-year growth 2021-2026 (%)
o 5.4 Autoimmune diseases - Market size and forecast 2021-2026
o Exhibit 32: Chart on Autoimmune diseases - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Autoimmune diseases - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Autoimmune diseases - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Autoimmune diseases - Year-over-year growth 2021-2026 (%)
o 5.5 Metabolic conditions - Market size and forecast 2021-2026
o Exhibit 36: Chart on Metabolic conditions - Market size and forecast 2021-2026 ($ million)
o Exhibit 37: Data Table on Metabolic conditions - Market size and forecast 2021-2026 ($ million)
o Exhibit 38: Chart on Metabolic conditions - Year-over-year growth 2021-2026 (%)
o Exhibit 39: Data Table on Metabolic conditions - Year-over-year growth 2021-2026 (%)
o 5.6 Others - Market size and forecast 2021-2026
o Exhibit 40: Chart on Others - Market size and forecast 2021-2026 ($ million)
o Exhibit 41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
o Exhibit 42: Chart on Others - Year-over-year growth 2021-2026 (%)
o Exhibit 43: Data Table on Others - Year-over-year growth 2021-2026 (%)
o 5.7 Market opportunity by Therapeutic Area
o Exhibit 44: Market opportunity by Therapeutic Area ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 46: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 48: Chart on Geographic comparison
o Exhibit 49: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 50: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 66: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 Germany - Market size and forecast 2021-2026
o Exhibit 70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on Germany - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
o 7.9 UK - Market size and forecast 2021-2026
o Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 7.10 China - Market size and forecast 2021-2026
o Exhibit 78: Chart on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 79: Data Table on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 80: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 81: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.11 Japan - Market size and forecast 2021-2026
o Exhibit 82: Chart on Japan - Market size and forecast 2021-2026 ($ million)
o Exhibit 83: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
o Exhibit 84: Chart on Japan - Year-over-year growth 2021-2026 (%)
o Exhibit 85: Data Table on Japan - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 86: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 87: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 88: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 89: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 90: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 91: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 92: Matrix on vendor position and classification
o 10.3 Agilent Technologies Inc.
o Exhibit 93: Agilent Technologies Inc. - Overview
o Exhibit 94: Agilent Technologies Inc. - Business segments
o Exhibit 95: Agilent Technologies Inc. - Key news
o Exhibit 96: Agilent Technologies Inc. - Key offerings
o Exhibit 97: Agilent Technologies Inc. - Segment focus
o 10.4 B. Braun Melsungen AG
o Exhibit 98: B. Braun Melsungen AG - Overview
o Exhibit 99: B. Braun Melsungen AG - Business segments
o Exhibit 100: B. Braun Melsungen AG - Key news
o Exhibit 101: B. Braun Melsungen AG - Key offerings
o Exhibit 102: B. Braun Melsungen AG - Segment focus
o 10.5 Becton Dickinson and Co.
o Exhibit 103: Becton Dickinson and Co. - Overview
o Exhibit 104: Becton Dickinson and Co. - Business segments
o Exhibit 105: Becton Dickinson and Co. - Key news
o Exhibit 106: Becton Dickinson and Co. - Key offerings
o Exhibit 107: Becton Dickinson and Co. - Segment focus
o 10.6 Dedecke GmbH
o Exhibit 108: Dedecke GmbH - Overview
o Exhibit 109: Dedecke GmbH - Product / Service
o Exhibit 110: Dedecke GmbH - Key offerings
o 10.7 Merck KGaA
o Exhibit 111: Merck KGaA - Overview
o Exhibit 112: Merck KGaA - Product / Service
o Exhibit 113: Merck KGaA - Key offerings
o 10.8 Miltenyi Biotec B.V. and Co. KG
o Exhibit 114: Miltenyi Biotec B.V. and Co. KG - Overview
o Exhibit 115: Miltenyi Biotec B.V. and Co. KG - Product / Service
o Exhibit 116: Miltenyi Biotec B.V. and Co. KG - Key news
o Exhibit 117: Miltenyi Biotec B.V. and Co. KG - Key offerings
o 10.9 Shimadzu Corp.
o Exhibit 118: Shimadzu Corp. - Overview
o Exhibit 119: Shimadzu Corp. - Business segments
o Exhibit 120: Shimadzu Corp. - Key news
o Exhibit 121: Shimadzu Corp. - Key offerings
o Exhibit 122: Shimadzu Corp. - Segment focus
o 10.10 Stevanato Group S.p.A
o Exhibit 123: Stevanato Group S.p.A - Overview
o Exhibit 124: Stevanato Group S.p.A - Product / Service
o Exhibit 125: Stevanato Group S.p.A - Key offerings
o 10.11 Thermo Fisher Scientific Inc.
o Exhibit 126: Thermo Fisher Scientific Inc. - Overview
o Exhibit 127: Thermo Fisher Scientific Inc. - Business segments
o Exhibit 128: Thermo Fisher Scientific Inc. - Key news
o Exhibit 129: Thermo Fisher Scientific Inc. - Key offerings
o Exhibit 130: Thermo Fisher Scientific Inc. - Segment focus
o 10.12 West Pharmaceutical Services Inc.
o Exhibit 131: West Pharmaceutical Services Inc. - Overview
o Exhibit 132: West Pharmaceutical Services Inc. - Business segments
o Exhibit 133: West Pharmaceutical Services Inc. - Key news
o Exhibit 134: West Pharmaceutical Services Inc. - Key offerings
o Exhibit 135: West Pharmaceutical Services Inc. - Segment focus
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 136: Inclusions checklist
o Exhibit 137: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 138: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 139: Research methodology
o Exhibit 140: Validation techniques employed for market sizing
o Exhibit 141: Information sources
o 11.5 List of abbreviations
o Exhibit 142: List of abbreviations

zzzz
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Therapeutic Area
Exhibits6: Executive Summary – Chart on Incremental Growth
Exhibits7: Executive Summary – Data Table on Incremental Growth
Exhibits8: Executive Summary – Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Bargaining power of buyers – Impact of key factors in 2021 and 2026
Exhibits19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants – Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes – Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry – Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Therapeutic Area - Market share 2021-2026 (%)
Exhibits25: Data Table on Therapeutic Area - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Therapeutic Area
Exhibits27: Data Table on Comparison by Therapeutic Area
Exhibits28: Chart on Infectious diseases - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Infectious diseases - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Infectious diseases - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Infectious diseases - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Autoimmune diseases - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Autoimmune diseases - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Autoimmune diseases - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Autoimmune diseases - Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Metabolic conditions - Market size and forecast 2021-2026 ($ million)
Exhibits37: Data Table on Metabolic conditions - Market size and forecast 2021-2026 ($ million)
Exhibits38: Chart on Metabolic conditions - Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Metabolic conditions - Year-over-year growth 2021-2026 (%)
Exhibits40: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibits41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibits42: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibits43: Data Table on Others - Year-over-year growth 2021-2026 (%)
Exhibits44: Market opportunity by Therapeutic Area ($ million)
Exhibits45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits46: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits48: Chart on Geographic comparison
Exhibits49: Data Table on Geographic comparison
Exhibits50: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits82: Chart on Japan - Market size and forecast 2021-2026 ($ million)
Exhibits83: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
Exhibits84: Chart on Japan - Year-over-year growth 2021-2026 (%)
Exhibits85: Data Table on Japan - Year-over-year growth 2021-2026 (%)
Exhibits86: Market opportunity By Geographical Landscape ($ million)
Exhibits87: Impact of drivers and challenges in 2021 and 2026
Exhibits88: Overview on Criticality of inputs and Factors of differentiation
Exhibits89: Overview on factors of disruption
Exhibits90: Impact of key risks on business
Exhibits91: Vendors covered
Exhibits92: Matrix on vendor position and classification
Exhibits93: Agilent Technologies Inc. - Overview
Exhibits94: Agilent Technologies Inc. - Business segments
Exhibits95: Agilent Technologies Inc. - Key news
Exhibits96: Agilent Technologies Inc. - Key offerings
Exhibits97: Agilent Technologies Inc. - Segment focus
Exhibits98: B. Braun Melsungen AG - Overview
Exhibits99: B. Braun Melsungen AG - Business segments
Exhibits100: B. Braun Melsungen AG - Key news
Exhibits101: B. Braun Melsungen AG - Key offerings
Exhibits102: B. Braun Melsungen AG - Segment focus
Exhibits103: Becton Dickinson and Co. - Overview
Exhibits104: Becton Dickinson and Co. - Business segments
Exhibits105: Becton Dickinson and Co. - Key news
Exhibits106: Becton Dickinson and Co. - Key offerings
Exhibits107: Becton Dickinson and Co. - Segment focus
Exhibits108: Dedecke GmbH - Overview
Exhibits109: Dedecke GmbH - Product / Service
Exhibits110: Dedecke GmbH - Key offerings
Exhibits111: Merck KGaA - Overview
Exhibits112: Merck KGaA - Product / Service
Exhibits113: Merck KGaA - Key offerings
Exhibits114: Miltenyi Biotec B.V. and Co. KG - Overview
Exhibits115: Miltenyi Biotec B.V. and Co. KG - Product / Service
Exhibits116: Miltenyi Biotec B.V. and Co. KG - Key news
Exhibits117: Miltenyi Biotec B.V. and Co. KG - Key offerings
Exhibits118: Shimadzu Corp. - Overview
Exhibits119: Shimadzu Corp. - Business segments
Exhibits120: Shimadzu Corp. - Key news
Exhibits121: Shimadzu Corp. - Key offerings
Exhibits122: Shimadzu Corp. - Segment focus
Exhibits123: Stevanato Group S.p.A - Overview
Exhibits124: Stevanato Group S.p.A - Product / Service
Exhibits125: Stevanato Group S.p.A - Key offerings
Exhibits126: Thermo Fisher Scientific Inc. - Overview
Exhibits127: Thermo Fisher Scientific Inc. - Business segments
Exhibits128: Thermo Fisher Scientific Inc. - Key news
Exhibits129: Thermo Fisher Scientific Inc. - Key offerings
Exhibits130: Thermo Fisher Scientific Inc. - Segment focus
Exhibits131: West Pharmaceutical Services Inc. - Overview
Exhibits132: West Pharmaceutical Services Inc. - Business segments
Exhibits133: West Pharmaceutical Services Inc. - Key news
Exhibits134: West Pharmaceutical Services Inc. - Key offerings
Exhibits135: West Pharmaceutical Services Inc. - Segment focus
Exhibits136: Inclusions checklist
Exhibits137: Exclusions checklist
Exhibits138: Currency conversion rates for US$
Exhibits139: Research methodology
Exhibits140: Validation techniques employed for market sizing
Exhibits141: Information sources
Exhibits142: List of abbreviations